Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPACK Block vs Periarticular Infiltration in TKA
NCT03653416Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Mar 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Narcotic Consumption at 24 hours. Started Mar 2018; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03653416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03653416.